An international team, led by researchers at the University of California San Diego School of Medicine, has developed and validated a genetic tool for predicting age of onset of aggressive prostate cancer, a disease that kills more than 26,000 American men annually.
Cancer cells can be destroyed more effectively and selectively with a unique new reusable treatment, activated with a substance found in stinging nettles and ants - thanks to new research by the University of Warwick.
A team from Roswell Park Cancer Institute has discovered a unique population of normal stem cells that may enable prostate cancer relapse. These findings may point the way toward strategies for treating or preventing prostate cancer recurrence.
The new COL (Ret.) David G. McLeod Prostate Cancer Translational Research Fellowship was awarded to Dr. Prachi Mishra, Dec. 7 at the Uniformed Services University of the Health Sciences (USU), in a ceremony in front of Department of Defense and industry leaders, cancer scientists, military healthcare providers and other colleagues.
Men infected with HPV16, the type responsible for most HPV-related cancers, are 20 times more likely to be reinfected with the same type of HPV after one year. That is according to a new study published this month in the Proceedings of the National Academy of Sciences. The article shows the same effect in both men who are sexually active and celibate, suggesting that they are not reacquiring the virus from another sexual partner.
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative to tumor tissue sequencing, and it is intended to specifically detect and sequence tumor DNA circulating in patients’ blood. The results are used to help guide doctors to tailor the best treatment for patients at each point of their disease.
A new study from Keck Medicine of USC finds that data from a novel recorder can be used to objectively measure surgeons’ proficiency in robotic-assisted prostate cancer surgery.
Researchers are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options. The tool eventually will help patients with other cancers as well.
NIBIB-funded scientists have developed a new technique for 3D-printing patient-specific organ models – here the prostate gland -- using polymers that accurately model the prostate’s dimensions and physical properties, while also providing quantitative tactile feedback, or response to pressure, incisions, and suturing.
New research shows how losing a ubiquitous gene opens genetic floodgates that make prostate cancer deadly, a finding that could apply to many cancers.
Hackensack Meridian Health Bayshore Medical Center is proud to announce that it has expanded services to include targeted MRI ultrasound for prostate biopsy. The procedure utilizes both ultrasound and magnetic resonance imaging (MRI) to allow for better targeting within the prostate, enabling cancerous cells to be more easily detected.
To help empower women in low- and middle-income countries and improve their health, the U.S. Agency for International Development through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) awarded RTI International a $4.8 million cooperative agreement to develop a dual-purpose drug delivery device for both HIV and pregnancy prevention that can be successfully used in these settings.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
What men would like to see now is a shift from infertility being seen as a ‘women’s issue’ within society and vastly improved support for men, in particular online.
Study led by University of Maryland School of Social Work's Jodi Frey has resulted in more than 1,750 mental health screenings.
Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.
For the ninth year in a row, Loyola University Medical Center has received the American Heart Association/American Stroke Association's Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award.
A new translational research fellowship has been established to continue the pioneering work of retired Army Col. (Dr.) David G. McLeod, who devoted nearly 50 years to prostate cancer research and treatment as a military urologist. He retired in 2016 as founding director of the Center for Prostate Disease Research (CPDR) at the Uniformed Services University of the Health Sciences (USU).
Queen’s University Belfast are taking part in a global trial to test whether exercise should be prescribed to treat patients with advanced prostate cancer.
Mayo Clinic Monthly News Tips - October 2017 Headlines
The October tip sheet from Fred Hutchinson Cancer Research Center includes story ideas about a new take on prostate cancer screening; fruit fly obesity; nanoparticles for gene therapy; TCRs for relapsing leukemia and more. Each tip links to more detailed information and includes contact information for arranging interviews.
The PSA test does not specifically check for prostate cancer itself, but rather for the presence of a molecule in the blood naturally made by the prostate.Here are common factors to be aware of that could change your PSA test results.
A study led by UNC Lineberger Comprehensive Cancer Center researchers found that preference for preserving sexual function was not strongly reflected in the treatment choices of men with low-risk prostate cancer.
Soroush Rais-Bahrami, M.D., assistant professor in the Department of Urology and co-director for the UAB Program for Personalized Prostate Cancer Care.In 2016, more than 180,890 men will be diagnosed with prostate cancer, the second leading cause of cancer death in men. Next to skin cancers, prostate cancer is the most common cancer diagnosed in American men.
Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center.
In a study in today’s issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels to proliferate. Their earlier research—which first implicated nerves in fueling prostate cancer—has prompted Montefiore-Einstein to conduct a pilot study testing whether beta blockers (commonly used for treating hypertension) can kill cancer cells in tumors of men diagnosed with prostate cancer.
The world's "better" countries, with greater access to healthcare, experience much higher rates of cancer incidence than the world's "worse off" countries, according to new research from the University of Adelaide.
New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells.
Research led by St. Jude Children’s Research Hospital found meeting with fertility specialists and parental recommendations play key roles in decisions at-risk male cancer patients make about fertility preservation
Contrary to previous research, caffeine may not relieve movement symptoms for people with Parkinson’s disease, according to a study published in the September 27, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The National Institutes of Health has awarded a $2.5 million grant to researchers at The University of Texas Health Science Center at Houston (UTHealth) to develop a standard protocol for anal cancer screenings for men who have sex with men.
When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may contribute to male infertility or congenital illness.
Leading Australian cancer researcher Professor Wayne Tilley has today been presented with a $2.5 million Breast & Prostate Cancer Linkage Grant, thanks to a groundbreaking collaboration between the National Breast Cancer Foundation (NBCF) and the Movember Foundation in Australia.
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It’s called fusion guided biopsy and it greatly improves on the standard biopsy technique.
Cancer is a real concern for many Americans. According to the fourth edition of the Mayo Clinic National Health Checkup, 95 percent of respondents take at least one preventive measure to avoid cancer.
A novel mitochondrial variant of the protein Syntaphilin, or SNPH, which orchestrates the choice between cancer cell proliferation and metastasis in response to oxygen and nutrient shortage in the tumor microenvironment, has been identified by researchers at The Wistar Institute.
Close to 70 percent of men with erectile dysfunction (ED) respond to the ED drug sildenafil. However, only about 50 percent of men with diabetes—a population commonly affected by ED—achieve positive results with sildenafil. Researchers from the Smooth Muscle Research Centre at the Dundalk Institute of Technology, in Dundalk, Ireland, are studying two new drugs that may give men with diabetes—and others for whom conventional treatment is ineffective—new hope for treating ED.
Scientists have found distinctive portions of genetic material—known as lncRNAs—that help sperm develop. Male mice lacking a particular lncRNA have low sperm count, suggesting lncRNAs could represent novel infertility drug targets.
A new Michigan State University study now offers new details showing that a certain protein released from fat in the body can cause a non-cancerous cell to turn into a cancerous one. The federally funded research also found that a lower layer of abdominal fat, when compared to fat just under the skin, is the more likely culprit, releasing even more of this protein and encouraging tumor growth.
Researchers have found a mutation in the gene for the growth hormone receptor that promotes longevity, increasing men’s lifespan by an average of 10 years. This finding emerged from a new study led by Prof. Gil Atzmon of the University of Haifa. “We were aware before that variants involved with genetic paths related to the growth hormone are also associated with longevity. Now we have found a specific variant whose presence or absence is directly connected to it,” Prof. Atzmon explains.
Theo Courtesy: Thomas & Friends Thomas & Friends is set to introduce a new line of "experimental engines," including Theo, who is described as genuinely kind and caring, but with an awkward habit of blunt speaking. He also has a geared drive system that often does not run smoothly, making sudden jolts when his cogs jam.
Data from the Corporal Michael J. Crescenz Veterans Affairs Medical Center in Philadelphia showed that doctors there were ordering bone scans at three times the national rate for a certain group of prostate cancer patients. It called for a coaching visit to the pitcher's mound.
A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.
ROCHESTER, Minn. — Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.
School-based mental health programs can reach large numbers of children, with increasing evidence of effectiveness in improving mental health and related outcomes, according to a research review in the September/October issue of the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer.
The overall rate of stroke in the United States has been declining in recent years and while that has been good news, a new study suggests it may be primarily good news for men. The research, published in the August 9, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology, found that while the stroke rate for men declined during the study period, for women it remained the same.
Researchers are investigating mobile DNA segments, known as L1 insertions, in sperm cells with the long-term goal of preventing birth defects by treating at-risk individuals, prior to conceiving a child.
As published in JNCCN – Journal of the National Comprehensive Cancer Network, researchers at UT Southwestern Medical Center found significant racial and gender-based disparities in outcomes among patients with locoregional anal cancer.
Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body. The scientists say their cell culture and mouse studies of the process, which involves a cancer-related protein called AIM1, suggest potential ways to intercept or reverse the ability of cancers to metastasize, or spread.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right